M Pharmaceutical Announces Rebranding for Subsidiary

M Pharmaceutical (CSE:MQ; OTCQB:MPHMF) announced it will change the name of its subsidiary M Pharmaceutical USA to Callitas Therapeutics.
As quoted in the press release:

The name of the parent company remains as it is for now.
A clinical-stage company developing innovative technologies for weight management and female health and wellness, the new name reflects its broader commitment to drive the innovations needed to shape the future of healthcare. The new corporate website is now – www.callitas.com.
“Our new name, Callitas Therapeutics, reflects our wide-ranging business objective of developing and delivering innovative technologies for weight management and female health and wellness,” said Gary Thompson, President and CEO of Callitas Therapeutics and M Pharma. “As a company with its roots in female health and wellness, we are committed to delivering breakthrough products and services that truly improve daily living. Aligning our logo with the beautiful and strong Calla Lily seems most appropriate in light of our mission.”

Click here to read the full press release.

Source: www.accesswire.com